RDUS Stock UPDATES Radius Health Inc. (RDUS) 15.98 09/09/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Radius Health Inc. (RDUS) 15.98 $RDUS

Radius Health to Host Scientific Panel Discussion for Investors on Investigational Drug Abaloparatide at ASBMR 2014
GlobeNewswire - Mon Sep 08, 6:36AM CDT
Live Panel And Conference Call Scheduled for 7:30 a.m. CDT on September 15, 2014

Radius Health Reports Proof of Mechanism for RAD1901 and Presentation at 4th Annual Brain Metastases Research and Emerging Therapy Conference in September
GlobeNewswire - Thu Aug 28, 4:19PM CDT
Radius Health, Inc. ("Radius" (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases, reports that the positron emission tomography (PET) imaging from the RAD1901 maximum tolerated dose study ("MTD" has demonstrated potent selective estrogen receptor degradation ("SERD" activity. In the ongoing MTD study, we observed via 18F-fluroestradiol positron emission tomography that a well tolerated dose of RAD1901 strongly suppressed positive baseline estrogen receptor imaging sites in the first healthy volunteer in the PET imaging cohort of the study. The study will continue to test higher doses to determine the maximum tolerated doses and to extend the PET imaging correlation with the pharmacokinetic/pharmacodynamic response to RAD1901.

Radius Health Announces Presentations at the American Society for Bone and Mineral Research 2014 Annual Meeting
GlobeNewswire - Tue Aug 19, 6:37AM CDT
Radius Health, Inc. (Nasdaq:RDUS) announced today that it will present new data from multiple studies of abaloparatide in women with postmenopausal osteoporosis at the American Society for Bone and Mineral Research (ASBMR) 2014 Annual Meeting, which takes place September 12-15, 2014 in Houston, Texas.

Radius Health Reports Second Quarter 2014 Financial and Operating Results
GlobeNewswire - Tue Aug 12, 6:48AM CDT
Radius Health, Inc. ("Radius" (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases, reported its financial results for the second quarter ended June 30, 2014, and provided recent corporate highlights.

Radius Health to Present at the Canaccord Genuity 34th Annual Growth Conference
GlobeNewswire - Thu Aug 07, 9:43AM CDT
Radius Health (Nasdaq:RDUS) announced today that its President and CEO, Robert Ward, will present at the Canaccord Genuity 34th Annual Growth Conference on Wednesday, August 13, 2014 at 10:30 a.m. Eastern Time at the Intercontinental Hotel in Boston.

Radius Health to Announce Second Quarter 2014 Financial Results, Host Conference Call and Live Webcast on Aug 12, 2014
GlobeNewswire - Wed Aug 06, 6:57AM CDT
Radius Health (Nasdaq:RDUS) announced today that it will release its second quarter 2014 financial results on Tuesday, August 12, 2014.

Nasdaq stocks posting largest percentage increases
AP - Tue Aug 05, 5:06PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:

Radius Health, Inc. (NASDAQ: RDUS) to Ring The NASDAQ Stock Market Closing Bell
GlobeNewswire - Wed Jul 30, 9:07AM CDT
What:

Oxford Immunotec Appoints Louis O'Dea Chief Medical Officer
GlobeNewswire - Mon Jul 07, 6:00AM CDT
Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, commercial-stage diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology, today announced that Louis O'Dea, MB, BCh, BAO, has joined the company as Chief Medical Officer. Dr. O'Dea brings to Oxford Immunotec more than 20 years of worldwide pharmaceutical, medical device, and biotechnology industry management experience. Dr. O'Dea will support the continued growth of our current T-SPOT.TB business and the development of new products through management of our medical education and clinical trial programs. Prior to joining Oxford Immunotec, Dr. O'Dea served as the Chief Medical Officer and Head of Regulatory Affairs at Moderna Therapeutics. Prior to Moderna, he was Chief Medical Officer of Radius Health, Inc. and Head of Clinical Development for the Metabolic and Reproductive Health unit of Serono, a division of Merck.

Oxford Finance and Solar Capital Close $30 Million Senior Debt Facility with Radius Health
PR Newswire - Tue Jul 01, 8:00AM CDT
Oxford Finance LLC ("Oxford" , a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a $30 million senior secured term loan agreement with Radius Health, Inc. ("Radius Health" . The financing was provided to Radius Health from both Oxford and Solar Capital Ltd. ("Solar Capital" . Proceeds of the loan will be used for working capital and to advance the development of Radius Health's lead candidate, abaloparatide, along with other products.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rachel Noble Joins AGS: Signals Strategy Shift

Updated Category News Views 92

A Tactical Addition to American Global Strategies The chessboard of global security just saw a savvy new player join American Global Strategies (AGS). Rachel Noble, a name that echoes through the halls of Australia's national security apparatus, has joined AGS as Senior Advisor. This isn't your garden-variety hire—this is a strategic power move. From Down Under to the...

Continue Reading
Boosting Employability: English Skills in Italy's Job Market

Updated Category News Views 95

Tackling Language Barriers in Italy's Workforce If you're looking to make it big in Italy, you're facing a task that demands more than just regional expertise. The working world is no longer bound by borders, and for Italians eyeing international gigs, English fluency is a must-have. While not an absolute ticket to success, grasping English could be your career's booster...

Continue Reading
Third Lake Parts Ways with WaterView Retail Center

Updated Category News Views 55

Third Lake Partners Exits WaterView Retail in Florida Alright, you don't stumble across deals like this every day. Third Lake Partners just tossed the keys to their WaterView Retail Center in St. Petersburg, wrapping up the retail and residential parts under one roof with Walton Street Capital. It only took a cool five years since its completion in 2021, but hey, better...

Continue Reading
Longevity Tour Hits East Coast: Brecka's Mission

Updated Category News Views 94

Bringing Longevity to the East Coast This weekend, something interesting is happening on the East Coast of the U.S. Gary Brecka and his Ultimate Longevity Center (ULC) are holding a series of events in Philadelphia, New York, and Boston. Everything kicks off on November 14th. If the idea of 'live longevity' leaves you scratching your head, don’t worry—I've got you...

Continue Reading
Abbisko's PIMJETMI® Gains FDA Nod, Boosting TGCT Treatment

Updated Category News Views 35

PIMJETMI® Scores FDA Approval, Expanding Global Reach Well, here's something to chew on over your morning coffee—PIMJETMI® (pimicotinib) just snagged the U.S. FDA's blessing to treat tenosynovial giant cell tumor (TGCT), making it another notch on Abbisko Therapeutics' belt. This approval is a strategic home run for Abbisko and their pals at Merck KGaA, Darmstadt,...

Continue Reading
Creative Solutions Joins FICO Marketplace, Boosts AI Edge

Updated Category News Views 78

Creative Solutions and FICO Unite Well, we're diving into some strategic magic today. Creative Solutions International, not just your average marketing agency, has just hopped onto the FICO Marketplace platform. The word on the street is they're shaking things up with their Collections Marketing Platform. It's like giving your old financial letters a whole AI-driven paint...

Continue Reading
Envista's $430M Senior Notes: A Market Move Decoded

Updated Category News Views 97

Envista on the Move with $430M Notes Ever feel like the market's a bit like a rollercoaster with no brakes? That's kind of where we're at with Envista Holdings Corporation (NYSE: NVST) rolling out this new financial play. They just priced a hefty $430 million in Senior Notes at a solid 6.250% due 2033. In terms of the investment world, that's a pretty big splash. The...

Continue Reading
McEwen Faces Investigation Amid Declining Production

Updated Category News Views 35

MUX Investors on Alert as Legal Stakes Rise The gold mining world isn't exactly flooded with excitement these days, and McEwen Inc.'s (NYSE: MUX) latest dealings ain't doing much to brighten up the scenery. When their third-quarter gold output took a nosedive—a 23% drop to be exact—it caught more eyes than a bull market will. Production Guidance in Question Now,...

Continue Reading
Kemin Unveils LYSOFORTE ENFUSIO at EuroTier 2026

Updated Category News Views 158

Rollin' up to EuroTier 2026 with all its buzz—a place where big players in livestock production flex their muscles—Kemin Industries dropped a new ace in the feed deck: LYSOFORTE ENFUSIO. They're betting this bad boy will shake things up for poultry and pig nutritionists looking to maximize what's already on their plate without piling on more grain or feed costs....

Continue Reading
A Gentle Stake: Colts Neck's Rural Fight Ahead

Updated Category News Views 101

Michael Fazio's Gambit in Colts Neck If you're not fired up about land deals, you should be now. Michael Fazio, the owner of Synergy Stables in Colts Neck, New Jersey, is laying his cards on the table with a proposition for preserving the integrity of the township's rural landscape. Rather than cashing in on monstrous offers for high-density housing, Fazio's plan involves...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Investigation Underway for Investors of Xiao-I Corporation

Updated Category News Views 249

Faruqi & Faruqi, LLP Investigates Potential Claims for Investors Faruqi & Faruqi, LLP is taking a closer look at the recent financial struggles of Xiao-I Corporation. This is particularly important for investors who have incurred losses exceeding $50,000. If you fall within this category, it may be beneficial to reach out to their dedicated securities litigation partner,...

Continue Reading
Simmons First National Corporation: Transitioning Leadership Ahead

Updated Category News Views 126

Simmons First National Corporation Leadership Changes Simmons First National Corporation (NASDAQ: SFNC) has recently announced a significant change in its leadership structure. This decision marks a vital transition for the company as it prepares for the next chapter of its growth and development. Retirement Announcement of George Makris, Jr. After an impressive tenure,...

Continue Reading
Citi's Investment Strategy: Navigating the 2025 Market Landscape

Updated Category News Views 1295

Citi's Outlook for 2025: Sector Foresight Analysts at Citi have recently shared insights into their equity strategy for the upcoming year, outlining a balanced approach as investors navigate various macroeconomic factors and uncertainties in policy. Their comprehensive strategy, referred to as the "SIGN (Sector & Industry Group Navigator)," focuses on several key sectors...

Continue Reading
Insights on O3 Mining's Marban Alliance Economic Progress

Updated Category News Views 96

Updates on O3 Mining's Marban Alliance Project O3 Mining Inc. (TSXV: OIII | OTCQX: OIIIF) has announced a significant move forward in its flagship Marban Alliance project. The company has engaged G Mining Services Inc. to conduct a preliminary economic assessment (PEA) designed to refine the strategies for this promising gold-mining venture. With results anticipated in...

Continue Reading
Revving Up Vehicle Innovation: Sonatus at CES 2025

Updated Category News Views 539

Groundbreaking Innovations in Software-Defined Vehicles At CES 2025, Sonatus, a global trailblazer in software-defined vehicle (SDV) technologies, unveiled a remarkable array of products and solutions aimed at empowering original equipment manufacturers (OEMs) to unlock the potential of SDVs. The highlights included transformative contributions from Generative AI that...

Continue Reading